VeriMomtrigonella foenum-graecum seed extract은 임신 중 안전한가요?
No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
Pregnancy-safe products containing trigonella foenum-graecum seed extract
Related ingredients
Frequently asked questions
- trigonella foenum-graecum seed extract은 임신 중 안전한가요?
- No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
- trigonella foenum-graecum seed extract은 모유 수유 중 안전한가요?
- No regulatory ban or harmonised lactation hazard was identified. Clinical reviews note fenugreek has been used as an oral galactagogue and that safety data in nursing mothers/infants are limited and mixed; this is an oral systemic context, not topical cosmetic use. There is no authoritative CIR or SCCS safety opinion flagging breastfeeding risk for the cosmetic extract. (PubMed review; ECHA/COSING).
- trigonella foenum-graecum seed extract은 아기 피부에 안전한가요?
- No evidence of specific developmental or infant dermal toxicity was found and no regulatory restriction for use on infant skin was located. However, infant skin has higher permeability; for a botanical extract with measurable constituents, exposure via leave‑on topical use can be higher in babies — therefore exposure score is increased by +1 for 0–3 yr. No infant‑specific studies demonstrating placental/dermal transfer or endocrine disruption were found. (PubMed; COSING).
- VeriMom은 trigonella foenum-graecum seed extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 trigonella foenum-graecum seed extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 trigonella foenum-graecum seed extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.